| T cell exhaustion in glioblastoma: intricacies of immune checkpoints R Mirzaei, S Sarkar, VW Yong Trends in immunology 38 (2), 104-115, 2017 | 120 | 2017 |
| Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system KS Rawji, AMH Young, T Ghosh, NJ Michaels, R Mirzaei, J Kappen, ... Acta Neuropathologica 139, 893-909, 2020 | 104 | 2020 |
| Brain tumor-initiating cells export tenascin-C associated with exosomes to suppress T cell activity R Mirzaei, S Sarkar, L Dzikowski, KS Rawji, L Khan, A Faissner, P Bose, ... Oncoimmunology 7 (10), e1478647, 2018 | 100 | 2018 |
| Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer N Kheshtchin, S Arab, M Ajami, R Mirzaei, M Ashourpour, N Mousavi, ... Cancer Immunology, Immunotherapy 65, 1159-1167, 2016 | 89 | 2016 |
| Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis DK Kaushik, A Bhattacharya, R Mirzaei, KS Rawji, Y Ahn, JM Rho, ... The Journal of clinical investigation 129 (8), 3277-3292, 2019 | 88 | 2019 |
| Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor S Arab, N Kheshtchin, M Ajami, M Ashurpoor, A Safvati, A Namdar, ... Tumor Biology 39 (3), 1010428317695021, 2017 | 75 | 2017 |
| Activation of NOTCH signaling by tenascin-C promotes growth of human brain tumor-initiating cells S Sarkar, R Mirzaei, FJ Zemp, W Wei, DL Senger, SM Robbins, VW Yong Cancer research 77 (12), 3231-3243, 2017 | 73 | 2017 |
| Differential microglia and macrophage profiles in human IDH-mutant and-wild type glioblastoma CC Poon, PMK Gordon, K Liu, R Yang, S Sarkar, R Mirzaei, ST Ahmad, ... Oncotarget 10 (33), 3129, 2019 | 72 | 2019 |
| Lactobacillus crispatus strain SJ‐3C‐US induces human dendritic cells (DCs) maturation and confers an anti‐inflammatory phenotype to DCs S Eslami, J Hadjati, E Motevaseli, R Mirzaei, S Farashi Bonab, ... Apmis 124 (8), 697-710, 2016 | 52 | 2016 |
| Study of the tumor microenvironment during breast cancer progression R Eftekhari, R Esmaeili, R Mirzaei, K Bidad, S de Lima, M Ajami, ... Cancer cell international 17, 1-10, 2017 | 39 | 2017 |
| Control of brain tumor growth by reactivating myeloid cells with niacin S Sarkar, R Yang, R Mirzaei, K Rawji, C Poon, MK Mishra, FJ Zemp, ... Science Translational Medicine 12 (537), eaay9924, 2020 | 37 | 2020 |
| Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients S Mortezagholi, Z Babaloo, P Rahimzadeh, H Namdari, M Ghaedi, ... Immunopharmacology and Immunotoxicology 39 (1), 11-18, 2017 | 29 | 2017 |
| Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor‐initiating cells L Dzikowski, R Mirzaei, S Sarkar, M Kumar, P Bose, A Bellail, C Hao, ... Brain Pathology 31 (5), e12947, 2021 | 24 | 2021 |
| Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a … A Namdar, R Mirzaei, A Memarnejadian, R Boghosian, M Samadi, ... Cancer Immunology, Immunotherapy 67, 367-379, 2018 | 22 | 2018 |
| PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway R Mirzaei, A Gordon, FJ Zemp, M Kumar, S Sarkar, HA Luchman, ... Science Advances 7 (45), eabh2148, 2021 | 19 | 2021 |
| Myeloid-derived suppressor cells elimination by 5-fluorouracil increased dendritic cell-based vaccine function and improved immunity in tumor mice J Hadjati, A Namdar, R Boghozian, M Hafezi, M Ashourpour, ... Iranian Journal of Allergy, Asthma and Immunology, 47-55, 2018 | 19 | 2018 |
| Microglia induces Gas1 expression in human brain tumor-initiating cells to reduce tumorigenecity S Sarkar, CC Poon, R Mirzaei, KS Rawji, W Hader, P Bose, J Kelly, ... Scientific Reports 8 (1), 15286, 2018 | 15 | 2018 |
| In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors AK Bohm, J DePetro, CE Binding, A Gerber, N Chahley, ND Berger, ... Neuro-oncology 22 (8), 1150-1161, 2020 | 13 | 2020 |
| Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model A Pourgholaminejad, A Jamali, M Samadi-Foroushani, A Amari, R Mirzaei, ... Cellular immunology 271 (2), 360-364, 2011 | 13 | 2011 |
| Efficacy and safety of G2013 as a novel immunosuppressive agent on differentiation, maturation and function of human dendritic cells NA Fard, N Tabrizian, R Mirzaei, J Hadjati, FT Zavareh, ARS Nodeh, ... Iranian Journal of Public Health 46 (2), 216, 2017 | 12 | 2017 |
Jamshid HadjatiProfessor of Immunology, School of Medicine, Tehran University of Medical Sciences在 tums.ac.ir 的电子邮件经过验证
